Typhoid and paratyphoid fever
Top Cited Papers
- 1 August 2005
- journal article
- Published by Elsevier in The Lancet
- Vol. 366 (9487) , 749-762
- https://doi.org/10.1016/s0140-6736(05)67181-4
Abstract
No abstract availableKeywords
This publication has 173 references indexed in Scilit:
- Immune Responses to an Oral Typhoid Vaccine Strain That Is Modified to Constitutively Express Vi Capsular PolysaccharideThe Journal of Infectious Diseases, 2004
- Postmarketing Safety Surveillance for Typhoid Fever Vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002Clinical Infectious Diseases, 2004
- The Efficacy of aSalmonella typhiVi Conjugate Vaccine in Two-to-Five-Year-Old ChildrenNew England Journal of Medicine, 2001
- Azithromycin versus Ceftriaxone for the Treatment of Uncomplicated Typhoid Fever in ChildrenClinical Infectious Diseases, 2000
- Requirement of p21-activated Kinase (PAK) for Salmonella typhimurium–induced Nuclear ResponsesThe Journal of Experimental Medicine, 1999
- Re-emergence of chloramphenicolsensitive Salmonella typhiThe Lancet, 1999
- Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid feverEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Prevention of Typhoid Fever in Nepal with the VI Capsular Polysaccharide ofSalmonella TyphiNew England Journal of Medicine, 1987
- Summary of an International Workshop on Typhoid FeverClinical Infectious Diseases, 1986
- Reduction of Mortality in Chloramphenicol-Treated Severe Typhoid Fever by High-Dose DexamethasoneNew England Journal of Medicine, 1984